scPharmaceuticals Inc (SCPH)
3.46
+0.10
(+2.98%)
USD |
NASDAQ |
Nov 21, 16:00
3.31
-0.15
(-4.34%)
After-Hours: 20:00
scPharmaceuticals Shareholders Equity (Quarterly): 30.71M for Sept. 30, 2024
Shareholders Equity (Quarterly) Chart
Historical Shareholders Equity (Quarterly) Data
| Date | Value |
|---|---|
| September 30, 2024 | 30.71M |
| June 30, 2024 | 9.25M |
| March 31, 2024 | 24.57M |
| December 31, 2023 | 37.22M |
| September 30, 2023 | 49.15M |
| June 30, 2023 | 63.43M |
| March 31, 2023 | 75.81M |
| December 31, 2022 | 72.43M |
| September 30, 2022 | 31.11M |
| June 30, 2022 | 40.46M |
| March 31, 2022 | 49.39M |
| December 31, 2021 | 56.47M |
| September 30, 2021 | 63.11M |
| June 30, 2021 | 69.04M |
| March 31, 2021 | 75.52M |
| Date | Value |
|---|---|
| December 31, 2020 | 82.17M |
| September 30, 2020 | 89.82M |
| June 30, 2020 | 98.06M |
| March 31, 2020 | 55.10M |
| December 31, 2019 | 51.36M |
| September 30, 2019 | 57.89M |
| June 30, 2019 | 63.47M |
| March 31, 2019 | 70.40M |
| December 31, 2018 | 78.74M |
| September 30, 2018 | 83.39M |
| June 30, 2018 | 88.59M |
| March 31, 2018 | 97.94M |
| December 31, 2017 | 106.00M |
| September 30, 2017 | 19.65M |
| December 31, 2016 | -37.07M |
Shareholders' Equity Definition
Shareholder's Equity is a main portion of the balance sheet of a company that measures the net value of a company. The reason for this is because the from an accounting perspective, the balance sheet equation is Shareholder's Equity = Assets - Liabilities. A few examples of shareholder's equity of a company include retained earnings, paid in capital, and preferred stock.
Shareholders Equity (Quarterly) Range, Past 5 Years
9.25M
Minimum
Jun 2024
98.06M
Maximum
Jun 2020
56.21M
Average
55.79M
Median
Shareholders Equity (Quarterly) Benchmarks
| NovaBay Pharmaceuticals Inc | 1.072M |
| Palatin Technologies Inc | -7.686M |
| iBio Inc | 17.75M |
| Theriva Biologics Inc | 24.64M |
| Oragenics Inc | 3.078M |
Shareholders Equity (Quarterly) Related Metrics
| Total Assets (Quarterly) | 125.07M |
| Total Liabilities (Quarterly) | 94.36M |
| Debt to Equity Ratio | 1.664 |
| Current Ratio | 8.080 |
| Net Debt Paydown Yield | -1.17% |